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Abstract
Background: The numbers of margin-negative resections and survival times have greatly improved because of a more
aggressive surgical approach to resectable hilar cholanciocarcinoma (Klatskin tumour). It was shown initially by Japanese
authors that complete resection of the caudate lobe together with partial hepatectomy leads to more margin-negative
resections. However, this concept has not been unanimously taken up by Western authors. The aim of this study was to
examine the role of complete caudate lobe resection in our series of resected hilar cholangiocarcinomas. Methods: Between
January 1993 and January 2003, 54 patients underwent resection for Klatskin tumours. These patients were divided into two
groups, according to the two 5-year periods in which they had been operated. In the first period, patients did not routinely
undergo complete excision of the caudate lobe, whereas in the second period, partial liver resection was combined with
complete excision of the caudate lobe in 15 patients. These two patient groups were evaluated with respect to postoperative
morbidity and mortality, microscopic tumour margins and survival time. Results: Postoperative complications occurred in
59% of patients in total, while overall mortality was 11%. No difference was found in postoperative morbidity or mortality
between the two periods. A significantly higher number of margin-negative resections was found in the second 5-year period,
together with improved survival. Conclusion: Concomitant complete excision of segment 1 for patients with hilar
cholangiocarcinoma did not lead to increased morbidity or mortality. Therefore the addition of complete excision of
segment 1 is a safe procedure contributing to a higher rate of R0 resections and improved survival.
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Introduction
Due to the central anatomical position of Klatskin
tumours within the liver hilum, it has been difficult to
perform curative resections for this type of tumour.
During the last 15 years, a shift has taken place towards
a more aggressive approach in the treatment of hilar
cholangiocarcinoma [1–4]. Many authors have empha-
sized the importance of negative surgical margins
to improve survival after resection [5–7]. Mostly in
Bismuth–Corlette type II, III and IV tumours, this can
only be achieved by combining hilar resection with
partial liver resection [8]. Because of frequent anterior
and posterior ductal infiltration, partial hepatectomy
is advocated in combination with resection of seg-
ment 4 and complete excision of the caudate lobe.
Japanese surgeons in particular, convincingly demon-
strated a survival benefit of a more aggressive approach
including extended liver resection and concomitant
complete excision of segment 1 [2–4,9]. Despite these
results, complete excision of segment 1 has not been
fully implemented in the surgical treatment of hilar
cholangiocarcinoma by Western surgeons.
Also in our institution, as of the early 1990s, an
increasing number of patients with type III or IV hilar
cholangiocarcinoma underwent hilar resection in
combination with partial liver resection, occasionally
including part of segment 1. Starting in 1998, more
partial liver resections were performed for hilar
cholangiocarcinoma and these were routinely com-
bined with complete excision of the caudate lobe. The
aim of this study was to assess the outcome of patients
who underwent hilar resection and partial hepatectomy
with or without concomitant complete caudate lobe
resection with regard to postoperative morbidity and
mortality, microscopic tumour clearance and patient
survival.
Patients and methods
From January 1993 to January 2003, 54 patients
underwent resection for hilar cholangiocarcinoma in
our institution. Starting in 1998, a more aggressive
policy consisting of more extensive, partial liver
resections was adopted and these were combined with
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total excision of segment 1 in a total of 15 patients.
Resections were performed in 31 men and 23 women
with a mean age of 59.5+1.5 years (range 29–79
years). There was no statistical difference in gender or
mean age of patients who had undergone surgery
before and after 1998.
Preoperative workup
Preoperative assessment of patients with hilar
cholangiocarcinoma showed few changes during the
whole study period. The usual imaging techniques in
the two time periods included endoscopic retrograde
cholangiopancreatography (ERCP), ultrasound with
Doppler imaging and computed tomography (CT).
Diagnostic laparoscopy was used routinely to detect
small liver or peritoneal metastases in both study
groups [10]. Percutaneous transhepatic cholangio-
graphy (PTC) was used in one patient in the first
period and in five patients in the second period.
After 1998, CT scanning became more valuable and
was used more often, owing to improved scanning
techniques. It was used in 12 patients before 1998
(48%), and in 22 patients after 1998 (76%). As of the
end of 2000, MRCP was performed to assess vascular
ingrowth in six patients in total.
Tumour classification
The Bismuth–Corlette classification was used to
describe proximal tumour extension, preoperatively
as well as intraoperatively in all patients [8] (Table I).
Pathological evaluation during and after surgery
revealed an accurate preoperative diagnosis in 45
patients (83%). These patients were equally divided
between the two time periods.
Preoperative biliary drainage
To relieve jaundice and to optimize future remnant
liver function, preoperative biliary drainage was
performed in 48 patients (89%). ERCP was used in
46 (96%) patients and PTC was used in 6 patients
(13%); both techniques were used in four patients
(8%). The percentage of patients who had undergone
preoperative biliary drainage was 96% before 1998
and 83% after 1998.
Additional therapy
Low dose preoperative radiotherapy (3r3.5 Gy)
was given to all patients to prevent implantation
metastases [11]. Patients routinely underwent
postoperative radiotherapy (55 Gy) in both time
periods [12].
Table I. Bismuth–Corlette classification, types of resection and outcome of patients who had undergone resection for Klatskin tumors,
divided into two 5-year periods
1993–1998 1998–2003 Total
Total 25 29 p value 54
Bismuth type NS
Type I 4 (16%) 2 (7%) 6 (11%)
Type II 5 (20%) 5 (17%) 10 (19%)
Type IIIa 9 (36%) 12 (41%) 21 (39%)
Type IIIb 7 (28%) 8 (28%) 15 (28%)
Type IV 0 (0%) 2 (7%) 2 (4%)
Type of resection NS
Local resection 12 (48%) 8 (28%) 20 (37%)
Hilar resection+partial liver resection 13 (52%) 21 (72%) 34 (63%)
(Extended) right hemihepatectomy 7(6) (54%) 11(7) (52%) 18 (53%)
Left hemihepatectomy 6 (46%) 10 (48%) 16 (47%)
Complete segment 1 resection NA
Local resection 0 (0%) 0 (0%) 0 (0%)
Hilar resection+partial liver resection 0 (0%) 15 (52%) 15 (28%)
Portal vein reconstruction NS
Yes 1 (4%) 6 (21%) 7 (13%)
No 24 (96%) 23 (79%) 47 (87%)
In-hospital morbidity NS
Yes 13 (52%) 19 (66%) 32 (59%)
No 12 (48%) 10 (34%) 21 (41%)
In-hospital mortality NS
Yes 3 (12%) 3 (10%) 6 (11%)
No 22 (88%) 26 (90%) 48 (89%)
Margin-negative resections (R0) 8 (32%) 17 (59%) 40.05 25 (46%)
Local resection 3 (38%) 5 (29%)
Hilar resection+partial liver resection 5 (63%) 12 (71%)
Complete segment 1 resection 0/0 (0%) 10/15 (67%)
NS, not significant; NA, not applicable.
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Statistical analysis
The w2 test and Fisher’s exact test were used to
assess the significance of differences between groups.
Numeric data were evaluated using independent-
samples t test and were expressed as mean+standard
error of the mean (SEM). The Kaplan-Meier method
was used to construct survival curves and the log-rank
significance test was used for comparison of survival
between groups. SPSS 10.0.7 for Windows (SPSS Inc.,
Chicago, IL, USA) was used as statistical software
and a p value 50.05 was considered significant.
Results
Bismuth types
Table I shows the definitive Bismuth types obtained
during or after surgery. There were no statistically
significant differences in Bismuth type between
patients in the two study groups. Most partial liver
resections were performed in patients with type III
tumours (67%).
Types of resection
The types of resection that were performed were as
follows: local resection for type I tumours, local
resection with partial excision of segment 1 and/or 4
for type II tumours and hilar resections in combination
with (extended) right or left hemihepatectomy for
type IIIa and IIIb tumours, respectively. Extended
right hemihepatectomy was performed in 13 patients.
The two type IV tumours were treated with hilar
resection and left hemihepatectomy and in one of these
patients a portal vein reconstruction was performed.
Portal vein reconstruction was performed in seven
patients in total. As of 1998, complete excision of
segment 1 was performed in combination with hilar
resection and partial hepatectomy in 15 patients
(52%). Apart from concomitant segment 1 excision,
no statistical differences were found in types of
resection in the two study periods.
Morbidity and mortality
Overall, postoperative complications, including minor
and major procedure-related complications, occurred
in 59% of the patients (Table I). No significant
differences were found in the rate of postoperative
complications in the two study periods. The most
frequently occurring complications were liver failure,
bile leakage and liver abscess or intra-abdominal
abscesses (data not shown). The hospital mortality
was 12% in the first and 10% in the second period
(Table I). All six patients ultimately died due to multi-
organ failure. In five of these patients, multi-organ
failure was preceded by liver failure, whereas in one
patient sepsis was the main cause of multi-organ failure
and subsequent death.
Histopathological examination
The microscopic resection and dissection margins were
analysed, along with tumour differentiation, invasion
into perineural tissue and lymph node involvement.
Significantly more patients had undergone a margin-
negative (R0) resection in the second period, compared
with the first period (59% vs 32%, respectively,
p50.05). There were no differences in tumour
differentiation, invasion into perineural tissue or
lymph node involvement between the two study groups
(data not shown).
Survival
The mean overall survival of the two patient groups
was 4.8 years with a 95% confidence interval (CI) of
3.4–6.1 years. The overall 1-, 2- and 5-year survival
rates were 78%, 54% and 38%, respectively. Figure 1
shows the survival curves for the two periods. The
mean survival time in group 1 and 2 was 3.6 years
(CI 2.1–5.2) and 3.7 years (CI 3.0–4.5), respectively.
Survival was significantly longer in the second period
(p50.05). A total of 21 patients were still alive at the
completion of the study: 4 in the first and 17 in the
second period. As more than 50% of patients in
the second period are still alive, the median survival
times were not assessed.
Discussion
The outcome of surgical treatment for hilar cholangio-
carcinoma has improved during the last 10–15 years.
This is largely due to the fact that more resections
are combined with partial hepatectomy, leading to
more margin-negative resections [5–7]. In addition,
Japanese authors in the late 1990s and early 1990s
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Figure 1. Survival curves of all patients, divided into two 5-year
periods. The solid line represents the period 1993–1998 while the
dotted line represents the period 1998–2003. A significantly better
survival was found in the period 1998–2003 (p50.05).
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reported that combining hilar resection and partial
hepatectomy with complete caudate lobe resection
further increased the rate of margin-negative resections
[3,4]. Tsao and colleagues stated that this procedure
can be performed safely, in the hands of experienced
surgeons who are familiar with caudate lobe anatomy
[9]. These findings resulted in implementation of this
concept by other Japanese and some Western surgeons
[13,14].
The caudate lobe, designated as segment 1 in
Couinaud’s segmental classification of the liver, con-
stitutes 5–10% of the entire liver mass. Segment 1 is
composed of three portions, i.e. the Spiegel lobe
located to the left and dorsally to the inferior vena
cava, the paracaval portion lying anteriorly to the
inferior caval vein and the caudate process traversing
between the inferior vena cava and the portal vein, from
the paracaval portion to segment 7 of the right liver
[15]. The blood supply to segment 1 is independent
and originates mainly from the left portal vein and left
hepatic artery. Bile ducts from segment 1 may drain
into any part of the hepatic duct confluence, but most
frequently enter the left hepatic duct near the hepatic
duct confluence. Because of the proximity of segment 1
posterior to the hepatic duct confluence, the segment
1 biliary ducts are frequently involved in Klatskin
tumours, necessitating en bloc removal of the entire
lobe along with the hepatic duct confluence in curative
resections. Total excision of the caudate lobe was
advocated, since the incidence of caudate bile duct
invasion by hilar cholangiocarcinoma was indeed
found in 31–98% of cases [3,4,9]. Incomplete removal,
usually of the caudate process alone, does not suffice
for radical excision of all tumour. In the present series,
all segment 1 excisions were performed in conjunction
with partial liver resection in the second 5-year period
of the study. Although local excision, along the same
lines, may require en bloc removal of segment 1, most
local excisions in the second period of this series were
performed for Bismuth type I or II tumours, in which
tumour infiltration into the segment 1 bile ducts is less
frequent. The type III and IV tumours that were
treated by local excision were intentionally palliative
resections. In case of type II Klatskin tumours, we now
choose to undertake local resection in combination
with excision of segment 1, preferably in combination
with partial liver resection.
As of 1998, we applied the concept of complete
excision of segment 1 along with partial hepatectomy in
our institution. In this study, patients who had under-
gone resection for hilar cholangiocarcinoma were
analysed retrospectively during a 10-year period and
were divided into two 5-year periods, the second
starting in 1998. No significant differences were found
in tumour types according to the Bismuth–Corlette
classification or types of resection between these
groups, although more hilar resections in combination
with partial liver resections were performed in the later
period (72% vs 52% in the first period) [8]. There were
also no differences in accuracy of preoperative imaging
or other general characteristics of patients, such as age
and gender. The surgical team remained the same in
both periods.
The overall postoperative morbidity rate of 59% in
this study is comparable to that found in recent series,
in which postoperative morbidity varies from 37% to
85% [7,15,16]. When recent literature is compared
to more than 5-year-old literature, a slight increase
in postoperative morbidity has occurred, which is in
keeping with a generally adopted, more aggressive
surgical approach in the treatment of Klatskin tumours
[1–4]. The addition of complete excision of segment 1
in the second period did not lead to an increase in
postoperative complications or mortality in this study,
even though more portal vein resections were also
performed in this period.
In recent literature, overall mortality rates vary
from 0% to 10% [7,16,17]. In the first 5-year period,
mortality in this series was 12% whereas in the second
5-year period, mortality was 10%. Liver failure was the
most important cause of multi-organ failure and
subsequent death in this study, underscoring the need
for methods to accurately predict and to optimize
future remnant liver function.
Significantly more margin-negative resections were
performed in the second 5-year period. Apart from the
addition of complete segment 1 resection, increased
surgical experience and the tendency to perform more
extended resections, i.e. hilar resections in combina-
tion with partial liver resection, may have contributed
to this improved outcome. Despite the short follow-up
of patients in the second period, a significantly
increased survival was found compared with the first
period. The increased rate of margin-negative resec-
tions obviously is the most significant factor to
determine improved survival, as has repeatedly been
shown in the literature [4,6,9]. Because of the small
number of patients in this study, univariate and
multivariate analysis were not performed.
In conclusion, concomitant complete excision of
segment 1 for patients with hilar cholangiocarcinoma
did not lead to increased morbidity or mortality. The
addition of complete excision of segment 1 therefore,
is a safe procedure that can lead to a higher rate of
R0 resections and increased survival.
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